Risk factors for mortality among drug-resistant tuberculosis patients registered for drug-resistant treatment in Amhara region, Ethiopia: a historical cohort study.
Daniel Bekele KetemaMuluneh AleneMoges Agazhe AssemieLeltework YismawMehari Woldemariam MeridPublished in: Archives of public health = Archives belges de sante publique (2020)
This study concluded that drug-resistant tuberculosis mortality remains high in the study site. Age 45 years and above, smoking cigarette, tuberculosis related clinical complication, being anemic at baseline, HIV/AID, previous tuberculosis treatment history, and diabetes mellitus were identified risk factors for mortality. Continual support of the integration of TB/HIV service with emphasis and working on identified risk factors may help in reducing drug-resistant tuberculosis mortality.
Keyphrases
- drug resistant
- mycobacterium tuberculosis
- multidrug resistant
- hiv aids
- risk factors
- acinetobacter baumannii
- cardiovascular events
- pulmonary tuberculosis
- antiretroviral therapy
- hiv infected
- human immunodeficiency virus
- hiv positive
- end stage renal disease
- hepatitis c virus
- ejection fraction
- healthcare
- smoking cessation
- chronic kidney disease
- adverse drug
- emergency department
- coronary artery disease
- type diabetes
- peritoneal dialysis
- adipose tissue
- skeletal muscle
- south africa
- pseudomonas aeruginosa